MB07133

· Ligand Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MB07133, covering 2011-08-12 to 2023-11-21. Get the full timeline:

Most recent: Clinical Trial Update: MB07133 for the Treatment of Patients With Unresectable Hepatocellular Carcinoma [Phase 2]